Recall of Romesec Capsules 20mg from Singapore market (SIN11081P) for batch number #3963179 and 19010069 due to unacceptable product degradation
Healthcare professional
Therapeutic Products
14 August 2019
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
A Dear Healthcare Professional Letter has been issued by Ranbaxy (Malaysia) Sdn. Bhd. to inform that two batches of Romesec Capsules 20mg are being recalled due to the unacceptable product degradation, which may potentially result in the loss of product efficacy. Healthcare professionals using the affected batches are advised to follow the recommendations described in the letter and to return the affected capsules. Please refer to the letter for details.
Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of these letters can be found in the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://hpp.moh.gov.sg and follow the procedures below to access the MOH Alert system.
Step 1: Select your profession under ‘For Healthcare Professionals’.
Step 2: Click on ‘Useful links’.
Step 3: Click on ‘MOH Alert’ and log in via Singpass.
Step 4: Click on ‘Drug Alerts’ or ‘Med Device Alerts’ to view the DHCPLs.
